MedImpact starts roadshow for $225 million seven-year secured notes

By Paul A. Harris

Portland, Ore., Jan. 26 - MedImpact Holdings, Inc. started a roadshow on Wednesday for a $225 million offering of seven-year senior secured notes (Caa2), according to an informed source.

The Rule 144A for life deal is expected to price during the week ahead.

Credit Suisse, Bank of America Merrill Lynch and Jefferies & Co. are the joint bookrunners.

The notes come with four years of call protection.

The San Diego-based pharmacy benefits management company will use the proceeds to repay third-party claims and revolver debt, as well as for general corporate purposes and to fund a dividend.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.